Bedrijfsoverzicht
Healthcare Triangle, Inc. is a specialized healthcare information technology enterprise dedicated to engineering comprehensive solutions across cloud services, data science, and professional managed services for electronic health records within the healthcare and life sciences sectors. The company operates within the broader Healthcare sector, specifically focusing on the Health Information Services industry, which entails providing critical digital infrastructure for medical data management and operational efficiency. Its operational scale is defined by a market capitalization of $2.77M, an annual revenue of $12.94M based on trailing twelve months data, and an employed workforce of 59 individuals. These financial metrics collectively indicate that the company functions as a small-cap entity with a relatively modest revenue base compared to large-cap healthcare technology peers, suggesting a niche market position where growth potential is tied to expanding its suite of software solutions rather than established scale.
Financiële gezondheid
The company reported revenues of $12.94M over the trailing twelve months, yet it recorded a net income of $-6,321,000 and an EBITDA of $-5,914,000, revealing a significant structural gap between top-line growth and profitability. This substantial disparity between revenue and net income highlights an aggressive cost structure or high operating expenses that currently outweigh earnings before interest, taxes, depreciation, and amortization, resulting in a negative bottom line. Furthermore, the free cash flow stands at $-11,508,500, indicating that the company is consuming more cash than it generates from operations, which limits its immediate financial flexibility and ability to fund expansion without external capital. Margin analysis shows a gross margin of 13.1%, reflecting the cost of goods sold relative to sales, while the operating margin sits at a negative -74.3% and the profit margin at -48.8%, signaling that overhead costs and administrative expenses are consuming the majority of the revenue stream. Regarding liquidity and leverage, the company holds $1.63M in cash against $1.53M in debt, resulting in a debt-to-equity ratio of 17.53, which suggests a balance sheet that is technically leveraged but maintains a conservative current ratio of 2.03 to cover short-term obligations. Finally, the return on equity is recorded at -183.0% and the return on assets at -39.3%, metrics that demonstrate that management is currently utilizing shareholder capital and assets to generate negative returns rather than positive value creation.
Waarderingsbeoordeling
Valuation metrics for Healthcare Triangle, Inc. present a complex picture, with a trailing P/E ratio listed as N/A and a forward P/E of -0.08, implying that the market does not price the stock based on current earnings but rather anticipates a future earnings trajectory that could potentially turn positive. The price-to-book ratio is 0.14, which indicates that the market values the company at significantly less than its book value, suggesting a deep discount to assets or a high perceived risk premium. Additionally, the price-to-sales ratio stands at 0.21 and the EV/EBITDA is -1.29, offering alternative perspectives that suggest the company is valued primarily on its revenue base rather than profitability, a common characteristic for small-cap growth firms still in a loss-making phase. In terms of trading range, the stock has a 52-week high of $7470.00 and a 52-week low of $2.24, meaning the current price sits extremely close to the lower bound of this historical range, well below the peak valuation observed during the recent period. The beta value is 1.16, which explains that the stock price exhibits higher volatility relative to the broader market, moving with greater intensity than the S&P 500 during periods of market fluctuation.
Growth & Income
The company demonstrates robust top-line expansion with a revenue growth rate of 44.6% year-over-year, while earnings growth is N/A due to the current lack of profitability, indicating that revenue expansion is occurring independently of immediate earnings recovery. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it operates as a non-dividend payer that reinvests all available earnings and cash flows back into the business to fuel growth initiatives rather than distributing income to shareholders. The overall growth and income profile is characterized by strong revenue acceleration coupled with negative earnings and no dividend distribution, reflecting a classic high-risk, high-growth investment pattern typical of early-stage technology companies in the healthcare sector. This financial structure implies that any future value creation will depend on the company's ability to convert its accelerating revenue into positive net income and free cash flow to support the current leverage levels.